Overview


Apheresis Systems Market is envisioned to value over US $ 4 billion by the end of 2032 and record at a CAGR of over 7% during the forecast period of 2024-2032.

Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting.

The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for the market growth.

The Asia Pacific account significant share in the global market and created potential opportunities for international players due to increasing government support. It is majorly dominated by domestic manufacturers and expected to remain the same throughout the forecast period. Whereas, developed economies like North America, Europe witnessed strong penetration due to the increasing prevalence and stringent regulatory conditions. US, UK, France, Japan, and Germany account a major share in the global market due to high penetration. Latin America and Rest of World regions witnessed fast growth rate during the forecast period due to increasing adoption.

  • TERUMO BCT, INC.
  • Fresenius Kabi
  • B. Braun Melsungen AG,
  • Asahi Kasei Medical Co., Ltd
  • Macopharma
  • Grifolss
  • Delcon Medical Devices

By Product Type

  • Standalone Apheresis Systems
  • Portable Apheresis Systems
  • Consumables and Supplies

By End User

  • Hospitals
  • Outpatient Centres
  • Blood Banks

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Apheresis Systems Market By Product Type, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.   Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2. Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Apheresis Systems Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Apheresis Systems Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Neuroplasticity Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Apheresis Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Apheresis Systems Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •  1. Standalone Apheresis Systems
       2. Portable Apheresis Systems
       3. Consumables and Supplies

  • 8.  Apheresis Systems Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •  1. Hospitals
       2. Outpatient Centres
       3. Blood Banks

  • 9.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031  

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. TERUMO BCT, INC.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Fresenius Kabi
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. B. Braun Melsungen AG
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Asahi Kasei Medical Co., Ltd
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Macopharma
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Grifolss
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Delcon Medical Devices
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview

  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients